Synthesis of some novel dibromo-2-arylquinazolinone derivatives as cytotoxic agents

Zeinab Faghih , Nasrin Rahmannejadi, Razieh Sabet, Kamiar Zomorodian, Mohammad Asad, Soghra Khabnadideh

Abstract


Recently the quinazoline derivatives have attracted much attention for their anticancer properties. In this study a series of new brominated quinazoline derivatives (1a-1g) were synthesized in two steps. In the first step we used N-bromosuccinimide to brominate the anthranilamid. Then in the second step we closed the quinazoline ring by different aromatic aldehydes. Our aldehydes contain different electron donating or electron withdrawing groups at different positions of the aromatic ring. The chemical structures of products were confirmed by spectroscopic methods such as IR, 1HNMR, 13CNMR, and mass spectroscopy. The cytotoxic activities of the compounds were assessed on three cancerous cell lines including MCF-7, A549, and SKOV3 using colorimetric MTT cytotoxic assay in comparison with cisplatin as a standard drug. Our results collectively indicated that 1f and 1g, exhibited the best anti-proliferative activities on three investigated cancerous cell lines.


Keywords


Anticancer; Cytotoxicity; MTT; Quinazolinone.

Full Text:

PDF

References


Huang KH, Veal J, Barta T, Smith ED, Ma W, Ommen A. Quinazoline derivatives for the treatment of cancer. Google Patents EP3173084A1, 2010.

Arnold LD. 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents. Google Patents US5736534A, 1998.

Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the childhood cancer survivor study. J Clin Oncol. 2001;19(13):3163-3172.

DiMauro EF, Newcomb J, Nunes JJ, Bemis JE, Boucher C, Buchanan JL, et al. Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity. J Med Chem. 2006;49(19):5671-5686.

Khan I, Ibrar A, Abbas N, Saeed A. Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications. Eur J Med Chem. 2014;76:193-244.

Khan I, Ibrar A, Ahmed W, Saeed A. Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue. Eur J Med Chem. 2015;90:124-169.

Asif M. Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives. Int J Med Chem. 2014;2014. Article ID 395637.

Kale M, Patwardhan K. Synthesis of heterocyclic scaffolds with anti-hyperlipidemic potential: a review. Der Pharma Chemica. 2013;5(5):213-222.

Chandrika PM, Yakaiah T, Rao AR, Narsaiah B, Reddy NC, Sridhar V, et al. Synthesis of novel 4, 6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines. Eur J Med Chem. 2008;43(4):846-852.

Anand PV, Kumar KS, Sivakumar R, Solomon WS, Jayaveera K. Synthesis of quinazoline derivatives and their biological activities. Asian J Chem. 2009;21(9):6656-6660.

Jafari E, Khajouei MR, Hassanzadeh F, Hakimelahi GH, Khodarahmi GA. Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities. Res Pharm Sci. 2016;11(1):1-14.

Chandrika PM, Ram Rao AR, Narsaiah B, Raju MB. Quinazoline derivatives with potent anti-inflammatory and anti-allergic activities. Int J Chem Sci. 2008;6(3):1119-1146.

Al-Omar M, El-Azab AS, El-Obeid H, Abdel Hamide S. Synthesis of some new 4-(3H)-quinazoline analogs as potential antioxidant agents. J Saudi Chem Soc. 2006;10(1):113-130.

Al-Obaid AM, Abdel-Hamide SG, El-Kashef HA, Abdel-Aziz AAM, El-Azab AS, Al-Khamees HA, et al. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. Eur J Med Chem. 2009;44(6):2379-2391.

Faghih Z, Rezaei Z, Jamshidzadeh A, Faghih Z, Heidari N, Khabnadideh S. Cytotoxic evaluation of some new and potent azole derivatives as antimicrobial agents. TIPS. 2017;3(3):143-8.

Rahmannejadi N, Zomorodian K, Faghih Z, Faghih Z, Khabnadideh S, Yavari I. Preparation, docking, antimicrobial and cytotoxic activities of 2-arylquinazolinones. Br J Pharm Res. 2017; 20(3),1-11.

Faghih Z, Neshat A, Wojtczak A, Faghih Z, Mohammadi Z, Varestan S. Palladium (II) complexes based on schiff base ligands derived from ortho-vanillin; synthesis, characterization and cytotoxic studies. Inorganica Chim Acta. 2018;471:404-412.

Witt A, Bergman J. Recent developments in the field of quinazoline chemistry. Curr Org Chem. 2003;7(7):659-677.

Michael JP. Quinoline, quinazoline and acridone alkaloids. Nat Prod Rep. 1999;16(6):697-709.

Lin JP, Zhang FH, Long YQ. Solvent/oxidant-switchable synthesis of multisubstituted quinazolines and benzimidazoles via metal-free selective oxidative annulation of arylamidines. Org lett. 2014;16(11):2822-2825.

Kabri Y, Crozet MD, Redon S, Vanelle P. One-pot chemoselective synthesis of 2, 4, 6, 8-tetrasubstituted quinazolines via microwave-assisted consecutive bis-snar/bis-suzuki–miyaura cross-coupling reactions. Synthesis. 2017. DOI: 10.1055/s-0033-1341105.

Ahmed MF, Jaiash D, Belal A. Synthesis and design of new bromoquinazoline derivatives with anti-breast cancer activity. Acta Pol Pharma. 2017;74(5):1437-1445.

Patel HU, Patel RS, Patel CN. Synthesis and antihypertensive activity of some quinazoline derivatives. J Appl Pharm Sci. 2013;3(3):171-174.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.